These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22963627)
1. In vitro studies of water-stable cationic carbosilane dendrimers as delivery vehicles for gene therapy against HIV and hepatocarcinoma. de Las Cuevas N; Garcia-Gallego S; Rasines B; de la Mata FJ; Guijarro LG; Muñoz-Fernández MÁ; Gómez R Curr Med Chem; 2012; 19(29):5052-61. PubMed ID: 22963627 [TBL] [Abstract][Full Text] [Related]
2. Amphiphilic cationic carbosilane-PEG dendrimers: synthesis and applications in gene therapy. Sánchez-Nieves J; Fransen P; Pulido D; Lorente R; Muñoz-Fernández MÁ; Albericio F; Royo M; Gómez R; de la Mata FJ Eur J Med Chem; 2014 Apr; 76():43-52. PubMed ID: 24565572 [TBL] [Abstract][Full Text] [Related]
3. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells. Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914 [TBL] [Abstract][Full Text] [Related]
4. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. Bermejo JF; Ortega P; Chonco L; Eritja R; Samaniego R; Müllner M; de Jesus E; de la Mata FJ; Flores JC; Gomez R; Muñoz-Fernandez A Chemistry; 2007; 13(2):483-95. PubMed ID: 17004291 [TBL] [Abstract][Full Text] [Related]
5. Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration. Bravo-Osuna I; Vicario-de-la-Torre M; Andrés-Guerrero V; Sánchez-Nieves J; Guzmán-Navarro M; de la Mata FJ; Gómez R; de Las Heras B; Argüeso P; Ponchel G; Herrero-Vanrell R; Molina-Martínez IT Mol Pharm; 2016 Sep; 13(9):2966-76. PubMed ID: 27149661 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of cationic carbosilane dendrimers via click chemistry and their use as effective carriers for DNA transfection into cancerous cells. Arnáiz E; Doucede LI; García-Gallego S; Urbiola K; Gómez R; Tros de Ilarduya C; de la Mata FJ Mol Pharm; 2012 Mar; 9(3):433-47. PubMed ID: 22201256 [TBL] [Abstract][Full Text] [Related]
7. Water-stable ammonium-terminated carbosilane dendrimers as efficient antibacterial agents. Rasines B; Hernández-Ros JM; de las Cuevas N; Copa-Patiño JL; Soliveri J; Muñoz-Fernández MA; Gómez R; de la Mata FJ Dalton Trans; 2009 Oct; (40):8704-13. PubMed ID: 19809746 [TBL] [Abstract][Full Text] [Related]
8. Carbosilane dendrimers with phosphonium terminal groups are low toxic non-viral transfection vectors for siRNA cell delivery. Herma R; Wrobel D; Liegertová M; Müllerová M; Strašák T; Maly M; Semerádtová A; Štofik M; Appelhans D; Maly J Int J Pharm; 2019 May; 562():51-65. PubMed ID: 30877030 [TBL] [Abstract][Full Text] [Related]
9. Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes. Pedziwiatr-Werbicka E; Shcharbin D; Maly J; Maly M; Zaborski M; Gabara B; Ortega P; de la Mata FJ; Gómez R; Muñoz-Fernandez MA; Klajnert B; Bryszewska M J Biomed Nanotechnol; 2012 Feb; 8(1):57-73. PubMed ID: 22515094 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of cationic carbosilane dendrimers for sustainable protein sample preparation. González-García E; Sánchez-Nieves J; de la Mata FJ; Marina ML; García MC Colloids Surf B Biointerfaces; 2020 Feb; 186():110746. PubMed ID: 31877444 [TBL] [Abstract][Full Text] [Related]
11. Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers. Martínez Á; Fuentes-Paniagua E; Baeza A; Sánchez-Nieves J; Cicuéndez M; Gómez R; de la Mata FJ; González B; Vallet-Regí M Chemistry; 2015 Oct; 21(44):15651-66. PubMed ID: 26361378 [TBL] [Abstract][Full Text] [Related]
12. Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair. Marson D; Laurini E; Posocco P; Fermeglia M; Pricl S Nanoscale; 2015 Mar; 7(9):3876-87. PubMed ID: 25340619 [TBL] [Abstract][Full Text] [Related]
13. Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1. Shcharbin D; Pedziwiatr E; Nowacka O; Kumar M; Zaborski M; Ortega P; de la Mata FJ; Gómez R; Muñoz-Fernandez MA; Bryszewska M Colloids Surf B Biointerfaces; 2011 Apr; 83(2):388-91. PubMed ID: 21145713 [TBL] [Abstract][Full Text] [Related]
14. Interaction of cationic carbosilane dendrimers and their complexes with siRNA with erythrocytes and red blood cell ghosts. Wrobel D; Kolanowska K; Gajek A; Gomez-Ramirez R; de la Mata J; Pedziwiatr-Werbicka E; Klajnert B; Waczulikova I; Bryszewska M Biochim Biophys Acta; 2014 Mar; 1838(3):882-9. PubMed ID: 24316171 [TBL] [Abstract][Full Text] [Related]
15. Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1. Vacas-Córdoba E; Maly M; De la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ Int J Nanomedicine; 2016; 11():1281-94. PubMed ID: 27103798 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide. Sepúlveda-Crespo D; Lorente R; Leal M; Gómez R; De la Mata FJ; Jiménez JL; Muñoz-Fernández MÁ Nanomedicine; 2014 Apr; 10(3):609-18. PubMed ID: 24135563 [TBL] [Abstract][Full Text] [Related]
17. Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection. Perisé-Barrios AJ; Jiménez JL; Domínguez-Soto A; de la Mata FJ; Corbí AL; Gomez R; Muñoz-Fernandez MÁ J Control Release; 2014 Jun; 184():51-7. PubMed ID: 24721235 [TBL] [Abstract][Full Text] [Related]
18. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. Weber N; Ortega P; Clemente MI; Shcharbin D; Bryszewska M; de la Mata FJ; Gómez R; Muñoz-Fernández MA J Control Release; 2008 Nov; 132(1):55-64. PubMed ID: 18727943 [TBL] [Abstract][Full Text] [Related]
19. Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1. Briz V; Serramía MJ; Madrid R; Hameau A; Caminade AM; Majoral JP; Muñoz-Fernández MA Curr Med Chem; 2012; 19(29):5044-51. PubMed ID: 22963636 [TBL] [Abstract][Full Text] [Related]
20. Potential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes. Parboosing R; Chonco L; de la Mata FJ; Govender T; Maguire GE; Kruger HG Int J Nanomedicine; 2017; 12():317-325. PubMed ID: 28115849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]